Sirolimus or paclitaxel drug eluting stent in left main disease: The winner is⋯

International Journal of Cardiology

Volumn 152, Issue 3, 2011, Pages 387-

  Navarese, Eliano Pio ^a   Kubica, Jacek ^b   Gurbel, Paul A ^c  

^a MARIA CECILIA HOSPITAL   (Italy)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^c SINAI CENTER FOR THROMBOSIS RESEARCH   (United States)

Author keywords

Left main coronary artery disease; Paclitaxel stent; Sirolimus stent

Indexed keywords

PACLITAXEL; RAPAMYCIN;

CORONARY ARTERY OBSTRUCTION; COVARIANCE; DRUG EFFICACY; DRUG ELUTING STENT; FOLLOW UP; HAZARD RATIO; HUMAN; LEFT CORONARY ARTERY; LETTER; MORTALITY; PRIORITY JOURNAL; PROPENSITY SCORE; RISK ASSESSMENT; RISK FACTOR; SAMPLING ERROR; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

EID: 80055036967     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.08.024     Document Type: Article

References (5)

1. K.W. Park, S.H. Kang, and K.H. Park Sirolimus- vs. paclitaxel-eluting stents for the treatment of unprotected left main coronary artery stenosis: complete 2-year follow-up of a two-center registry Int J Cardiol 151 2011 Aug 18 89 95
2. P.S. Song, D.R. Ryu, and Y.B. Song Long-term outcomes of sirolimus-eluting stents vs. paclitaxel-eluting stents in unprotected left main coronary artery bifurcation lesions Clin Cardiol 34 2011 378 383
3. M. Toyofuku, T. Kimura, and T. Morimoto Three-year outcomes after sirolimus-eluting stent implantation for unprotected left main coronary artery disease: insights from the j-Cypher Registry Circulation 120 2009 1866 1874
4. D.W. Hosmer, T. Hosmer, S. Le Cessie, and S. Lemeshow A comparison of goodness-of-fit tests for the logistic regression model Stat Med 16 1997 965 980
5. G. Heinze, and P. Jüni An overview of the objectives of and the approaches to propensity score analyses Eur Heart J 32 2011 1704 1708